Dallas clinical trial testing new approach to ALS gives patients & doctors hope
A Phase 2 study is testing COYA 302, an experimental immune-system approach to ALS that aims to reduce inflammation and slow progression.
31 Jul 16:51 · 5 NBCDFW
Dallas clinical trial testing new approach to ALS gives patients & doctors hope
A Phase 2 study is testing COYA 302, an experimental immune-system approach to ALS that aims to reduce inflammation and slow progression.
31 Jul 16:51 · 5 NBCDFW
last updated on 31 Jul 23:26